NKTR logo

NKTR
Nektar Therapeutics

8,619
Mkt Cap
$787.28M
Volume
759,253.00
52W High
$66.92
52W Low
$6.48
PE Ratio
-4.57
NKTR Fundamentals
Price
$36.23
Prev Close
$37.68
Open
$36.10
50D MA
$50.41
Beta
2.10
Avg. Volume
954,933.18
EPS (Annual)
-$8.68
P/B
8.37
Rev/Employee
$1.61M
Loading...
Loading...
News
all
press releases
Short Interest in Nektar Therapeutics (NASDAQ:NKTR) Rises By 52.3%
Nektar Therapeutics (NASDAQ:NKTR - Get Free Report) was the target of a large growth in short interest during the month of December. As of December 31st, there was short interest totaling 2,935,715...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Nektar Therapeutics (NASDAQ:NKTR) Trading Up 6.9% - Still a Buy?
Nektar Therapeutics (NASDAQ:NKTR) Trading Up 6.9% - Here's What Happened...
MarketBeat·4d ago
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar...
PR Newswire·6d ago
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar...
PR Newswire·13d ago
News Placeholder
Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics
Soleno Therapeutics leads a rebound in small drug stocks as innovation, pipeline progress and M&A activity fuel optimism for 2026.
Zacks·13d ago
News Placeholder
5 Small Drug Stocks to Buy as Industry Recovery Picks Up
Innovation is at its peak in the Zacks Medical-Drugs industry. SLNO, NKTR, RIGL, IRWD and MRKR may prove to be good additions to one's portfolio.
Zacks·14d ago
News Placeholder
Ignore Nektar Therapeutics Stock in 2026 and Load Up on This One Instead
Key PointsNektar Therapeutics has a promising lead drug candidate, but there is considerable risk involved...
Nasdaq News: Markets·15d ago
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar...
PR Newswire·20d ago
News Placeholder
Moody Aldrich Partners LLC Buys 28,304 Shares of Nektar Therapeutics $NKTR
Moody Aldrich Partners LLC grew its stake in Nektar Therapeutics (NASDAQ:NKTR - Free Report) by 62.3% in the third quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·20d ago
News Placeholder
Simplify Asset Management Inc. Buys 35,176 Shares of Nektar Therapeutics $NKTR
Simplify Asset Management Inc. boosted its stake in Nektar Therapeutics (NASDAQ:NKTR - Free Report) by 67.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·22d ago
<
1
2
...
>

Latest NKTR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.